Beta-2-microglobulin (β2M) loss is rarely found in distant metastases or dMMR adenomas and has been associated with improved prognosis, particularly adding prognostic value to the increased CD8+ T cell levels found in LS-CRC [77, 82, 83]. The gene discussed is CD8A; the disease is colorectal carcinoma.